RWD Advances Rare Disease R&D, Brings Hope to Patients
Patient registries are fast becoming a critical source of real world data (RWD), especially in rare disease research and development [...]
Leveraging RWD to Improve Outcomes for Patients With Mantle Cell Lymphoma
A collaboration between Janssen and Flatiron Health led to advancements in the research and care of patients with Mantle Cell [...]
Flatiron ResearchX On-Demand Webinar on RWE in Regulatory Submissions
Flatiron ResearchX invited real world evidence (RWE) and pharma leaders to discuss how RWE impacts submissions to regulatory bodies. Available [...]
Cerner’s First Chief Health Officer Seeks to Leverage EHR RWD to Predict Disease and Improve Patient Outcomes
According to Cerner, Nasim Afsar, MD, MBA, MHM will take on the position of Chief Health Officer in January 2022. [...]
RWE Expert and Economist Details Future Global Market Access and Pricing Trends
Economist Ulf Staginnus shared his thoughts on future trends for market access and drug pricing in a recent discussion with [...]
New Report Considers Use of Oncology RWE in Successful Submissions to the FDA
In a recent article published in Clinical Cancer Research, investigators analyzed successful submissions of oncology drugs to the Food and [...]
Certara Leaders Discuss Leveraging RWD to Advance R&D and Meet Global Payers’ Needs
Certara’s Lee Stern and Shawn Bates shared their thoughts on how real world data (RWD) can be leveraged to meet [...]
Veradigm Advances R&D and Patient Care Using RWD
Veradigm uses its Electronic Health Record (EHR) software to improve patient care and to advance clinical research using real world [...]
Aetion Publishes 2021 eBook Showcasing RWE in Successful FDA Submissions
Aetion has published an eBook following an investigation into when and how real world evidence (RWE) successfully supports submissions to [...]
Panalgo VP Discusses Changes to ICER’s Value Assessments Ahead of Mid-November Webinar
HealthEconomics.Com Founder and CEO Dr. Patti Peeples recently spoke with Panalgo’s Matt Sussman regarding changes to the value assessments carried [...]
Parexel VPs Discuss COVID-19, RWE, and New Challenges
Parexel’s Leanne Larson and Matthew Gordon shared their thoughts on the growing importance of real world evidence (RWE) in clinical [...]
AMCP Partnership Forum on Biosimilars Identifies Adoption Challenges and RWE Solutions
The Academy of Managed Care Pharmacy (AMCP) Partnership Forum met in December 2020 to discuss the use of biosimilars in [...]
Collaborative RWE Registry Promises Data Transparency
The Real World Evidence (RWE) Registry was formed by the International Society for Pharmacoeconomics and Outcomes (ISPOR), the International Society for [...]
Newly Launched Cerner Enviza Utilizes RWD to Advance R&D, Improve Patient Outcomes, and Reduce Healthcare Costs
Cerner has launched Cerner Enviza, an operating unit that will use real world data (RWD) to advance clinical research and improve [...]
Savana CEO and Founder Discusses Overcoming RWE Challenges and Ensuring Data Privacy
Savana CEO and Founder discussed challenges that arise when designing real world evidence (RWE) studies, including data privacy concerns, data [...]
RWE Brings Data Privacy Concerns and Solutions
The use of real world evidence (RWE) has put a spotlight on data privacy and regulatory concerns. Regulatory expert Jackie [...]
Investigators Use RWD to Identify Potential Alzheimer’s Drug
According to a new study using data from electronic health records (EHRs), bumetanide, a diuretic, could be used in patients [...]
ISPOR Article on the Growing Wearable Market and New Applications in Healthcare
A recent article featured in Value & Outcomes Spotlight details the growing use of wearables. These tools can be an [...]
HealthVerity’s RWD Platform Informs Government Response to COVID-19
HealthVerity’s IPGE platform has been a critical source of real world data (RWD) for public health agencies throughout the COVID-19 [...]
Register for Upcoming Webinar on RWD in Decentralized Clinical Trials
A webinar highlighting the benefits of decentralized clinical trials that incorporate real world data (RWD) will take place on November [...]
FDA Releases Draft Guidance on RWD in Pharma Submissions
The Food and Drug Administration (FDA) has released its draft guidance on real world data (RWD). The guidance is intended [...]
Data Expert Discusses 9 RWE Applications in Healthcare and Pharma R&D
Vice President of Business Development & Real World Evidence (RWE) at ArborMetrix Benjamin Echeazu discusses the growing use of RWE [...]
ISPOR Seeks Comments for FDA Guidance on RWD
The International Society for Pharmacoeconomics and Outcomes (ISPOR) is seeking comments for a draft guidance document published by the Food and [...]
Syntropy and UCI Unite in 5-Year RWD Collaboration to Improve Patient Outcomes
Syntropy and the University of California, Irvine (UCI) will collaborate in a five-year partnership intended to directly improve patient outcomes [...]
Syapse Announces RWD Partnership with Merck to Accelerate Oncology Research and Improve Patient Outcomes
Real world evidence (RWE) leader Syapse has announced a partnership with Merck. Together, the companies will utilize real world data [...]